JPS5931495B2 - 新規なペプチドの製造法 - Google Patents

新規なペプチドの製造法

Info

Publication number
JPS5931495B2
JPS5931495B2 JP49068814A JP6881474A JPS5931495B2 JP S5931495 B2 JPS5931495 B2 JP S5931495B2 JP 49068814 A JP49068814 A JP 49068814A JP 6881474 A JP6881474 A JP 6881474A JP S5931495 B2 JPS5931495 B2 JP S5931495B2
Authority
JP
Japan
Prior art keywords
lys
mmol
boc
formula
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49068814A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5082055A (cg-RX-API-DMAC7.html
Inventor
カ−ルソン ラ−ス
ルイス モルダ− ジヤン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring AB
Original Assignee
Ferring AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring AB filed Critical Ferring AB
Publication of JPS5082055A publication Critical patent/JPS5082055A/ja
Publication of JPS5931495B2 publication Critical patent/JPS5931495B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C07K14/6955—Corticotropin [ACTH] with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP49068814A 1973-06-18 1974-06-18 新規なペプチドの製造法 Expired JPS5931495B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7308509A SE407570B (sv) 1973-06-18 1973-06-18 Forfarande for framstellning av nya peptider med hog adrenokortikotrop verkan
SE7308509 1973-06-18

Publications (2)

Publication Number Publication Date
JPS5082055A JPS5082055A (cg-RX-API-DMAC7.html) 1975-07-03
JPS5931495B2 true JPS5931495B2 (ja) 1984-08-02

Family

ID=20317792

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49068814A Expired JPS5931495B2 (ja) 1973-06-18 1974-06-18 新規なペプチドの製造法

Country Status (4)

Country Link
JP (1) JPS5931495B2 (cg-RX-API-DMAC7.html)
FR (1) FR2233072B1 (cg-RX-API-DMAC7.html)
GB (1) GB1470809A (cg-RX-API-DMAC7.html)
SE (1) SE407570B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470114A1 (fr) * 1979-11-26 1981-05-29 Mac Kerns Kenneth Composes polypeptidiques et medicament les contenant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1965102A1 (de) * 1969-12-27 1971-07-01 Hoechst Ag Neue Tridekapeptide mit hoher adrenocorticotroper Wirkung und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
SE7308509L (cg-RX-API-DMAC7.html) 1974-12-19
SE407570B (sv) 1979-04-02
GB1470809A (en) 1977-04-21
FR2233072B1 (cg-RX-API-DMAC7.html) 1978-07-28
JPS5082055A (cg-RX-API-DMAC7.html) 1975-07-03
FR2233072A1 (cg-RX-API-DMAC7.html) 1975-01-10

Similar Documents

Publication Publication Date Title
US3853837A (en) Novel nonapeptide amide analogs of luteinizing hormone releasing factor
EP0355572B1 (de) Peptidderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0106404B1 (en) Peptides
US3817973A (en) Process for the preparation of cyclopeptides derived from polymyxins
CA1126261A (en) Polypeptides and processes for the synthesis thereof
JPS6317839B2 (cg-RX-API-DMAC7.html)
Scoffone et al. Synthesis of peptide analogs of the N-terminal eicosapeptide sequence of ribonuclease A. VII. Synthesis of Ile8, Orn10-and Ala8, Orn10-eicosapeptides
US3770715A (en) Acth active peptides having d serine as first aminoacid from n terminus and l ornithine as11 aminoacid
US3749703A (en) Asn15-bovine thyrocalcitonin
US3816385A (en) (ile3,leu4)-vasopressin analogs and intermediates
US3364193A (en) Undeca- and dodecapeptides related to methionyl-lysyl-bradykinin
JPS60226898A (ja) 新規ゴナドリベリン誘導体およびその製造方法
US3388112A (en) Acth active peptides modified at the nu-terminal position
DE2342862C3 (de) An beiden Kettenenden Reste von a -Aminooxycarbonsäuren aufweisende Peptide mit ACTH-Wirkung, Verfahren zu ihrer Herstellung und diese Peptide enthaltende Arzneimittel
EP0354820B1 (en) Novel peptide derivatives and anti-dementia agents
EP0227410A2 (en) Peptide derivatives, their production and use
Hofmann et al. Studies with the S-peptide-S-protein system: The role of glutamic acid-2, lysine-7, and methionine-13 in S-peptide1–14 for binding to and activation of S-protein
US4018754A (en) Novel polypeptides having ACTH-like action
Ferderigos et al. The effect of modifications of the A5 and A19 amino acid residues on the biological activity of insulin.[Leu5-A] and [Phe19-A] sheep insulins
US4315853A (en) Polyprenylpeptides and their production
US4071510A (en) Peptides having a high adrenocorticotropic effect and a method of producing the same
US3400118A (en) Intermediates in the preparation of secretin
US4089821A (en) Synthesis of peptide amides
US3767639A (en) Process for the preparation of secretin
US3230211A (en) 8-p-fluoro-l-phenylanyl bradykinin